AzTrials
AzTrials

Separation Anxiety DisorderPhase 2NCT00735995

Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway

A Phase 2 study testing Cognitive behavioral therapy (individual) and Cognitive behavioral therapy (group) in people with Separation Anxiety Disorder and Social Phobia, run by Regionsenter for barn og unges psykiske helse at 3 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy. Read more about this study

Who is it for?
Ages 7 to 12 years
What is being tested?
Cognitive behavioral therapy (individual) and Cognitive behavioral therapy (group)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
165 participants
Where
3 sitesNorway
Study dates
Aug 2008to Dec 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Primary diagnosis of separation anxiety disorder, social phobia or generalized anxiety disorder based on the ADIS interview schedule, DSM-IV criteria

Who cannot join

  • Pervasive Developmental Disorder
  • Psychotic symptoms
  • Intelligence score < 70
  • Use of medications with anxiety reducing effects during treatment
  • Neither parent competent in Norwegian language

Trial locations and contacts

3 sites in 1 country.

Norway3 sites
  • Akershus Universitetssykehus HF

    Lorenskog, 1478

  • Sykehuset Asker og Baerum, Baerum BUP

    Rud, 1309

  • Sykehus Telemark Helseforetak, Skien og Porsgrunn BUP

    Skien

Other trials in Norway

About this study

Official title: Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.

The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy.

Being tested
Cognitive behavioral therapy (individual), Cognitive behavioral therapy (group)
Medical subject headings
Anxiety, Separation, Phobia, Social, Generalized Anxiety Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioral therapy (individual)Behavioural

    The Coping Cat program, 12 weekly sessions, two additional parent meetings

  • Cognitive behavioral therapy (group)Behavioural

    The Coping Cat program, 12 weekly sessions, two additional parent meetings

Study groups in NCT00735995
Study groupRoleWhat they receive
AExperimentalIndividual CBT
Receives: Behavioral: Cognitive behavioral therapy (individual)
BExperimentalGroup CBT
Receives: Behavioral: Cognitive behavioral therapy (group)
CNo interventionWaiting-list control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youth

    Measured: post-treatment and 2 year follow-up

Secondary outcomes (2)
  1. Symptom score on the MASC

    Measured: post-treatment and 2 year follow-up

  2. CGAS

    Measured: post-treatment and 2 year follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2008 (estimated)
  2. Study startAug 2008
  3. Primary completionOct 2013
  4. Study completionDec 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
165 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00735995
Sponsor's protocol ID
186036/V50
Other IDs
186036
Status last verified
Sep 2018
First submitted
13 Aug 2008
Last updated
26 Sep 2018
Results posted
No
Data monitoring committee
No

Publications

  • Gere MK, Hagen KA, Villabo MA, Arnberg K, Neumer SP, Torgersen S. Fathers' mental health as a protective factor in the relationship between maternal and child depressive symptoms. Depress Anxiety. 2013 Jan;30(1):31-8. doi: 10.1002/da.22010. Epub 2012 Oct 25.

    PubMed 23108976
  • Villabo MA, Cummings CM, Gere MK, Torgersen S, Kendall PC. Anxious youth in research and service clinics. J Anxiety Disord. 2013 Jan;27(1):16-24. doi: 10.1016/j.janxdis.2012.09.003. Epub 2012 Sep 25.

    PubMed 23257654
  • Villabø MA, Gere MK, Torgersen S, Arnberg K, Neumer SP, Kendall PC. Anxious self-statements in clinic-referred US and Norwegian anxiety-disordered youth. Cognitive Therapy and Research 37(4): 840-850, 2013.

  • Gere MK, Villabo MA, Torgersen S, Kendall PC. Overprotective parenting and child anxiety: the role of co-occurring child behavior problems. J Anxiety Disord. 2012 Aug;26(6):642-9. doi: 10.1016/j.janxdis.2012.04.003. Epub 2012 May 14.

    PubMed 22659077
  • Villabo M, Gere M, Torgersen S, March JS, Kendall PC. Diagnostic efficiency of the child and parent versions of the Multidimensional Anxiety Scale for Children. J Clin Child Adolesc Psychol. 2012;41(1):75-85. doi: 10.1080/15374416.2012.632350.

    PubMed 22233247
  • Villabo MA, Narayanan M, Compton SN, Kendall PC, Neumer SP. Cognitive-behavioral therapy for youth anxiety: An effectiveness evaluation in community practice. J Consult Clin Psychol. 2018 Sep;86(9):751-764. doi: 10.1037/ccp0000326.

    PubMed 30138014

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Cognitive behavioral therapy (individual) and Cognitive behavioral therapy (group) in people with Separation Anxiety Disorder and Social Phobia, run by Regionsenter for barn og unges psykiske helse at 3 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youth (time frame: post-treatment and 2 year follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00735995, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in